EC
NEO icon

EntryPoint Capital’s NeoGenomics NEO Stock Holding History

EntryPoint Capital’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Buy
+23,869
New +$230K 0.08% 483
2025
Q4 		– Sell
-23,176
Closed -$179K – 806
2025
Q3 		$179K Sell
23,176
-12,314
-35% -$86.3K 0.07% 570
2025
Q2 		$259K Buy
+35,490
New +$286K 0.13% 353
2024
Q3 		– Sell
-4,428
Closed -$61.4K – 1102
2024
Q2 		$61.4K Buy
+4,428
New +$62.8K 0.03% 1012

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

EntryPoint Capital's NEO Position: Q2 2026 in Review

EntryPoint Capital opened a new position in NeoGenomics (NEO) in Q2 2026: 23,869 shares worth $348K. The stake represents 0.08% of the portfolio and ranks #483 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in NEO as recently as Q3 2025.

EntryPoint Capital first reported a position in NEO in Q2 2024 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • EntryPoint Capital held 23,869 shares of NeoGenomics worth $348K as of Q2 2026.
  • NeoGenomics was a new EntryPoint Capital position in Q2 2026.
  • NeoGenomics made up 0.08% of EntryPoint Capital's portfolio in Q2 2026, its #483 holding.
  • EntryPoint Capital first reported a position in NeoGenomics in Q2 2024 and has held it in 4 quarters since.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.